Publications by the researcher in collaboration with ANA ISABEL ÁLVAREZ DE FELIPE (15)

2008

  1. Fluoroquinolone efflux mediated by ABC transporters

    Journal of Pharmaceutical Sciences, Vol. 97, Núm. 9, pp. 3483-3493

2007

  1. Absorption and metabolism of albendazole after intestinal ischemia/reperfusion

    European Journal of Pharmaceutical Sciences, Vol. 31, Núm. 1, pp. 16-24

  2. Effects of ischemia-reperfusion on the absorption and esterase metabolism of diltiazem in rat intestine

    Life Sciences, Vol. 80, Núm. 5, pp. 397-407

  3. Inhibitory effects of different antioxidants on hyaluronan depolymerization

    Carbohydrate Research, Vol. 342, Núm. 1, pp. 96-102

2006

  1. Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion

    Drug Metabolism and Disposition, Vol. 34, Núm. 4, pp. 690-695

  2. Interaction of enrofloxacin with breast cancer resistance protein (BCRP/ABCG2): Influence of flavonoids and role in milk secretion in sheep

    Journal of Veterinary Pharmacology and Therapeutics, Vol. 29, Núm. 4, pp. 279-287

  3. Interaction of probenecid with the breast cancer resistance protein transporter (BCRP/ABCG2)

    Letters in Drug Design and Discovery, Vol. 3, Núm. 4, pp. 236-241

  4. Role of ABC transporters in veterinary drug research and parasite resistance

    Current Drug Delivery, Vol. 3, Núm. 2, pp. 199-206

2005

  1. Comparative study of hyaluronic derivatives: Rheological behaviour, mechanical and chemical degradation

    International Journal of Biological Macromolecules, Vol. 35, Núm. 1-2, pp. 63-69

  2. Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2)

    Drug Metabolism and Disposition, Vol. 33, Núm. 5, pp. 614-618

2003

  1. Effect of clotrimazole on microsomal metabolism and pharmacokinetics of albendazole

    Journal of Pharmacy and Pharmacology, Vol. 55, Núm. 6, pp. 757-764

  2. Ginseng increases intestinal elimination of albendazole sulfoxide in the rat

    Comparative Biochemistry and Physiology - C Toxicology and Pharmacology, Vol. 136, Núm. 1, pp. 9-15

  3. Improved LC method to determine ivermectin in plasma

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 31, Núm. 4, pp. 639-645

  4. Intestinal elimination of albendazole sulfoxide: Pharmacokinetic effects of inhibitors

    International Journal of Pharmaceutics, Vol. 263, Núm. 1-2, pp. 123-132

  5. Mitochondrial, sarcoplasmic membrane integrity and protein degradation in heart and skeletal muscle in exercised rats

    Comparative Biochemistry and Physiology - C Toxicology and Pharmacology, Vol. 134, Núm. 2, pp. 199-206